B. Bang et al., Reduced 25-hydroxyvitamin D levels in primary Sjogren's syndrome - Correlations to disease manifestations, SC J RHEUM, 28(3), 1999, pp. 180-183
The purpose of this study was to explore the clinical and pathogenic signif
icance of vitamin D metabolites in primary Sjogren's syndrome (primary SS).
We measured blood concentrations of 25-hydroxyvitamin D (25 OH D) and calc
itriol (1, 25 (OH)(2) D)vc in 41 patients and correlated the results with b
lood levels of various immune activation products, as well as with patients
' clinical status. Levels of 25 OH D were slightly decreased as compared to
normal controls and the reduced levels of 25 OH D were stable over the obs
erved period of 2 years. Levels of 25 OH D correlated inversely with levels
of soluble interleukin-2 receptor, status indices for global disease, tota
l exocrine disease, surface exocrine disease, internal organ exocrine disea
se, and mediator-induced disease. Levels of 1,25 (OH)(2) D varied considera
bly and compared to normal control values. Levels of 1,25 (OH)(2) D did not
correlate with clinical/immunopathological status. In conclusion the inver
se correlations found between levels of 25 OH D and measures of clinical an
d immunoinflammatory status support the notion that vitamin D metabolism ma
y be involved in the pathogenesis of primary SS.